New Funding for Alto’s Mission
Today, we are excited to announce a $250 million Series D funding round, bringing our total funding to over $350M. We are honored to welcome Softbank to our team of investors and thrilled that our existing investors — including Greenoaks, Jackson Square Ventures, OliveTree Capital, and Zola Global — have reinvested to accelerate our mission to bring the Alto experience to 100 million people by 2025.
Over the past four years, we’ve delivered over 1 million prescriptions directly to our patients’ doors, and created a service that makes our patients happier — our patient NPS is over 80 for the fourth year in a row — and healthier — our medication adherence rate is 77% compared to an industry average of 50%.
This has been possible because we’ve learned from experienced community pharmacists, we’ve reimagined and rebuilt the underlying infrastructure of pharmacy, and, most important of all, we’ve built an amazing and diverse team that truly lives out our values every day. Never in my wildest dreams did I imagine I’d get to work on such a meaningful mission with such a genuinely passionate and talented team. Whenever I have a tough day and need a boost of energy, I walk through our pharmacies and look around in awe at all the hard work, care and perseverance that goes into making this type of service possible for our patients — from our pharmacists and patient care champions to our couriers and product managers, all working together.
This new round of funding will enable us to take everything we’ve built and learned over the past four years and bring it to more people and more patient demographics. I’ve seen many companies scale too quickly, hire too fast, and in that process lose sight of the heart of the company’s values and mission. What is most important to me as Alto enters this next chapter is that we maintain the same empathy and human connection we’ve had since we were a small community pharmacy.
I want to thank our team for joining us on this mission, to thank our investors for believing in us, and most importantly, I want to thank our patients for reminding me every day of why we’re on this journey.